Transparent Face Mask (NOT FDA-Approved) Aimed at Making Personal Protective Equipment More Inclusive Launches

September 17, 2020

CLAiRUS, Brooklyn, New York, recently announced the launch of CLAiRUS, a high-quality transparent face mask, which not only potentially reduces anxiety but also can help bridge the communication gaps commonly associated with typical non-transparent face masks and/or coverings. The excitement surrounding the new mask is skyrocketing.

CLAiRUS notes when it comes to day to day life, many people rely on lip-reading and facial expressions to be able to communicate effectively. Others are suffering from increased anxiety when faces are partially concealed from them by safety masks. As the country continues to make moves to address Covid-19 in the best ways, efforts are also being made to address issues like these, in the hopes of being more inclusive.

“We saw a real need for our transparent masks,” commented a spokesperson from the company. “The world is a happier place when it is more inclusive and that’s what we are working hard on trying to facilitate. The pandemic has been very hard on many people, and efforts like this, we believe, can really help. Protect and serve your community, be kind and be clear!”

According to CLAiRUS, the new mask is a non-medical, fully reusable mask. It’s not FDA-approved as a medical device and it’s also not officially certified as Personal Protective Equipment (PPE), but it has been specifically designed to help reduce the transmission of Covid-19. Of course, even when wearing the mask, the company points to the need to continue to practice social distancing, wash hands, and refraining from touching eyes or face.

SourceCLAiRUS

Hot this week

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”

Avery Dennison Medical Introduces Ipdated SilFoam Lite: Sustainability, MDR Certification & Performance Improvements

The newly enhanced SilFoam Lite delivers superior efficiency and reliability, bringing improved fluid handling capabilities and improved tack. These improvements make the product ideal for customers seeking quality, high-performance solutions in wound care notes Avery Dennison Medical.

Voluntary Recall Notifying Medtronic Insulin Pump Users of Potential Risks of Shortened Pump Battery Life

Medtronic plc voluntarily issued a field action starting on July 31, 2024, notifying global customers of its MiniMed™ 600 series or 700 series insulin pumps to follow their pump's built-in alerts and alarms for battery status and to contact Medtronic if they observe changes in the battery life of their pump

Medtronic Expands AiBLE Spine Surgery Ecosystem with New Technologies and Siemens Healthineers Partnership

New advancements in the AiBLE Spine Surgery ecosystem build upon the company's commitment to procedural innovation and execution

Axlab, Danish Medtech Pioneer, expands to US with Advanced Robotic Tissue Sectioning for Pathology Laboratories

Kris Rokke, National Sales Director for Axlab in the US. "My team and I are extremely excited and honored about this unique opportunity to also offer this advanced technology to labs across the US and thus contribute to the pathology labs of tomorrow."